Antinuclear antibodies by indirect immunofluorescence and solid phase assays

Ann Rheum Dis. 2020 Jun;79(6):e65. doi: 10.1136/annrheumdis-2019-215443. Epub 2019 May 10.

Xavier Bossuyt^{1

2}, Jolien Claessens^{3

4}, Ellen De Langhe⁵, Thibaut Belmondo⁶, Rene Westhovens⁵, Sophie Hue⁶, Koen Poesen^{3

7}, Daniel Blockmans^{2

8}, Michael Mahler⁹, Marvin J Fritzler¹⁰

¹ Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium xavier.bossuyt@uzleuven.be.
² Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
³ Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
⁴ Algemeen Klinisch Labo, Lier, Belgium.
⁵ Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.
⁶ Department of Laboratory Medicine, Henri Mondor Hospital, Créteil, France.
⁷ Department of Neurosciences, KU Leuven, Leuven, Belgium.
⁸ Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
⁹ Research and Development, INOVA Diagnostics, San Diego, California, USA.
¹⁰ Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

No abstract available

Keywords: autoimmune diseases; systemic lupus erythematosus; systemic sclerosis.

Publication types